Lefradafibán

Lefradafibán Uses, Dosage, Side Effects, Food Interaction and all others data.

Lefradafibán is an oral platelet glycoprotein IIb/IIIa receptor antagonist being investigated in the treatment of angina.

Lefradafibán, an orally active prodrug of fradafiban, is a novel glycoprotein (IIb/IIIa) inhibitor for the treatment of unstable angina. Development was discontinued in 2000 due to lack of efficacy.

Table Of contents

• Lefradafibán
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Lefradafibán
Generic	Lefradafiban
Lefradafiban Other Names	Lefradafibán, Lefradafiban, Léfradafiban, Lefradafibanum
Type
Formula	C23H25N3O6
Weight	Average: 439.4611 Monoisotopic: 439.174335547
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

For the treatment of unstable angina.

How Lefradafibán works

GPIIb/IIIa inhibitors, such as lefradafiban, block the final common pathway of platelet aggregation.

Innovators Monograph

You find simplified version here Lefradafibán